Portrait der Gilead Sciences Aktie
Das Unternehmen Gilead Sciences aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Gilead Sciences ist in mehr als 83 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Gilead Sciences mit 7,06% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Gilead Sciences Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Gilead Sciences am höchsten gewichtet ist Insgesamt in 83 ETFs enthalten
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
288 News & Informationen zur Gilead Sciences Aktie
World Health Organisation Covid-19 response betrays the principles upon which it was built
This article reveals how the World Health Organisation has strayed from its founding principles and how we can return to those principles.
9 Best Biotech ETFs to Play High-Octane Trends
Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.
AbbVie on Cusp of Getting Approval for Rinvoq in Ulcerative Colitis
GuruFocus Article or News written by Barry Cohen and the topic is about: Analysts think new indication could generate $2 billion in sales
Pharmaceutical Executive® APEX Awards Announces 2021 Finalists
/PRNewswire/ — Pharmaceutical Executive®, a leading multimedia platform for industry leaders to exchange experiences and insights about innovative business…
Pharmaceutical Executive® APEX Awards Announces 2021 Finalists
CRANBURY, N.J., July 8, 2021 /PRNewswire/ — Pharmaceutical Executive®, a leading multimedia platform for industry leaders to exchange experiences and
2 Top Global Value Stocks to Buy Now
Don't want to pay too steep a price for high-quality stocks? Look abroad.
APLA Health Launches AIDS Walk Los Angeles 2021 Hosted by Ongina of RuPaul's Drag Race
Los Angeles, CA, July 07, 2021 — Today, AIDS Walk Los Angeles 2021 is officially off and walking! APLA Health opens registration and fundraising for AIDS Walk LA at aidswalkla.org APLA…
APLA Health Launches AIDS Walk Los Angeles 2021 Hosted by Ongina of RuPaul's Drag Race
“The Walk Show” is the theme for AIDS Walk LA 2021…
Is Moderna’s leap with mRNA jabs really worth $100 billion?
The covid assumptions that justify its market value are too dicey
Hot Small-Cap Stocks To Watch With Potential Cancer Breakthroughs
Global Pulmonary Arterial Hypertension Market (2021 to 2026) – by Drug Class, Route of Administration, Distribution Mode and Geography
/PRNewswire/ — The “Global Pulmonary Arterial Hypertension Market (2021-2026) by Drug Class, Route of Administration, Distribution Mode, Geography,…
3 Biotech Stocks To Buy As Vaccinations Continue To Climb
Stocks Analysis by MarketBeat.com (Chris Markoch) covering: Gilead Sciences Inc, Amgen Inc, Illumina Inc, Moderna Inc. Read MarketBeat.com (Chris Markoch)'s latest article on Investing.com
Gene Therapy Market to Grow Substantially at 40.7% CAGR by 2025 – Report by Market Research Future (MRFR)
Gene Therapy Market Insights and Industry Analysis by Indication (Genetic Diseases, Oncology), By End-User (Hospitals & Clinics, Specialty Treatment…
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $68.86, moving +1.37% from the previous trading session.
4 Unstoppable Biotech Stocks to Buy Right Now By StockNews
4 Unstoppable Biotech Stocks to Buy Right Now
Top Biotech Companies by Market Cap
What are the biggest names in biotechnology? We count down the five top biotech companies based on market cap and share what they're up to.
A Biotech ETF to Track Nasdaq’s Industry-Setting Benchmark
As investors consider the regulatory, scientific, and demographic factors driving today’s growth in biotechnology industry…
Best Penny Stocks For Your July 2021 List? 8 Biotechs To Watch Now
Global Gene Therapy Market To Reach $2.7 Billion By 2026
SAN FRANCISCO, June 29, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Hedge Funds Have Never Been This Bullish On Canadian National Railway Company (CNI)
In this article we will analyze whether Canadian National Railway Company (NYSE:CNI) is a good investment right now by following the lead of some of the…
Will This 2020 Biotech IPO Crush the Market This Year?
Legend Biotech's CAR-T therapy's trial results were amazing, and could earn the treatment FDA approval in 2021.
Intellia Shares Soar on Positive Test Results
GuruFocus Article or News written by Barry Cohen and the topic is about: Merck, Sanofi, Gilead and others stand to benefit from clinical trials
2 Dividend Stocks That Can Help You Retire Early By StockNews
2 Dividend Stocks That Can Help You Retire Early
Buzzing Stocks: Thyrocare, Barbeque Nation, NALCO and other stocks in news today
Stocks In News: Check out the companies making the biggest headlines before the opening bell.
10 Best Dividend Stocks to Buy According to Billionaire Ken Griffin
In this article, we will discuss the 10 best dividend stocks to buy according to billionaire Ken Griffin. If you want to skip our detailed analysis of…
Invesco NASDAQ Biotech UCITS ETF: Folgt nach dem Aufschwung die Rallye?
Press Release : Roche's Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children
— The authorisation enables emergency use of Actemra/RoActemra for the
treatment of COVID-19 in hospitalised adult and paediatric patients
Basel, 25 June 2021 – Roche announced today… | June 25, 2021
Genentech's Actemra Receives FDA Emergency Use Authorization For The Treatment Of COVID-19 In Hospitalized Adults And Children
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed at $67.18 in the latest trading session, marking a +0.8% move from the prior day.
Redmile Group, LLC Buys Jazz Pharmaceuticals PLC, Seagen Inc, Medtronic PLC, Sells AbbVie Inc, Gilead Sciences Inc, 1Life Healthcare Inc
GuruFocus Article or News written by insider and the topic is about:
Here's Why Arcus Biosciences Stock Is Rising Today
Investors expecting Gilead Sciences to license Arcus Biosciences' lead asset could be in for an unpleasant surprise.
5 Rising Stocks in Gurus' Portfolios
GuruFocus Article or News written by Tiziano Frateschi and the topic is about: Suncor Energy makes the list
Treatment With Hepcludex® (Bulevirtide) Was Shown To Achieve Significant Response In Chronic Hepatitis Delta Virus After 24 Weeks
Gilead Sciences, Inc. (Nasdaq: GILD) today announced interim results from the Phase 2b and Phase 3 clinical trials evaluating the first-in-class entry inhibitor
China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876)
The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in ChinaIndividualized living-cell-based medicine: genetically m…
Venture Capital Access Online
Illicit covid-19 drugs bound for Mexico seized by US authorities
Possibly counterfeit or generic versions of Gilead’s remdesivir are reaching U.S. via airports
Unauthorized COVID-19 drugs bound for Mexico seized by U.S. authorities
Unauthorized COVID-19 drugs bound for Mexico seized by U.S. authorities – WSJ
8 Hot Biotech Penny Stocks For Your July 2021 Watch List
Illicit COVID-19 drugs bound for Mexico seized by US authorities
Criminal activity is on the uprise in U.S. airports, where federal authorities continue to seize illegal COVID-19 drugs trying to make their way to Mexico.
Kite Joint Venture – Fosun Kite – Gains The First CAR T-cell Therapy Approval In China
Kite, a Gilead Company, announced that Fosun Kite Biotechnology Co., Ltd., a joint venture between Kite and Shanghai Fosun Pharmaceutical (Group) Co., Ltd, has